A unanimous ruling on what a patent holder must allege when a generic label carves out the patented use.
In Recor Medical v. Medtronic Ireland, the Federal Circuit reversed a dismissal of patent infringement counterclaims and held that Medtronic Ireland's retained rights preserved its Article III standing.
In Versata Software v. Ford, the Federal Circuit reinstated $82.3M in damages and held that DTSA plaintiffs may elect unjust enrichment damages by statutory right.
US biotech firm Agensys has filed suit in California, accusing Suzhou Zelgen, Shanghai Zelgen, Gensun Biopharma, and Sheng of misappropriating its proprietary LRRC15 antibody technology to support a series of patent applications.
